These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964 [TBL] [Abstract][Full Text] [Related]
9. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729 [TBL] [Abstract][Full Text] [Related]
10. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812 [TBL] [Abstract][Full Text] [Related]
11. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors. Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; Bento MJ; Esteller M; Henrique R; Jerónimo C Mol Cancer; 2017 Jan; 16(1):26. PubMed ID: 28143614 [TBL] [Abstract][Full Text] [Related]
12. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. Fort RS; Mathó C; Geraldo MV; Ottati MC; Yamashita AS; Saito KC; Leite KRM; Méndez M; Maedo N; Méndez L; Garat B; Kimura ET; Sotelo-Silveira JR; Duhagon MA BMC Cancer; 2018 Feb; 18(1):127. PubMed ID: 29394925 [TBL] [Abstract][Full Text] [Related]
13. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792 [TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671 [TBL] [Abstract][Full Text] [Related]
18. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Li J; Kong F; Wu K; Song K; He J; Sun W Mol Med Rep; 2014 Nov; 10(5):2613-20. PubMed ID: 25215905 [TBL] [Abstract][Full Text] [Related]